Wolverine Trading, LLC Provention Bio, Inc. Transaction History

Wolverine Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$6.7 - $24.21 $73,854 - $266,866	11,023 New	11,023 $267,000
Q3 2022 Nov 14, 2022	BUY	$3.43 - $5.62 $44,981 - $73,700	13,114 New	13,114 $58,000
Q1 2022 May 16, 2022	SELL	$3.4 - $7.88 $36,247 - $84,008	-10,661 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.59 - $7.39 $59,594 - $78,784	10,661 New	10,661 $61,000
Q3 2021 Nov 12, 2021	SELL	$5.66 - $8.33 $200,114 - $294,515	-35,356 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$6.71 - $11.04 $237,238 - $390,330	35,356 New	35,356 $299,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.